Table 3.
Model 1 | Model 2 | Model 3 | |
---|---|---|---|
Non-CKD and CS = ll | reference | reference | reference |
Non-CKD and CS = 9–10 | 1.51 (1.23–1.85) | 1.22 (1.00–1.48) | 1.19 (0.98–1.45) |
Non-CKD and CS = 6–8 | 2.06 (1.64–2.59) | 1.31 (0.97–1.76) | 1.21 (0.91–1.62) |
Non-CKD and CS = 0–5 | 3.56 (2.67–4.73) | 1.64 (1.23–2.20) | 1.55 (1.14–2.10) |
CKD and CS = ll | 2.35 (1.82–3.04) | 1.73 (1.36–2.20) | 1.58 (1.23–2.03) |
CKD and CS = 9–10 | 3.36 (2.56–4.41) | 1.77 (1.24–2.52) | 1.62 (1.13–2.31) |
CKD and CS = 6–8 | 3.85 (2.78–5.32) | 1.91 (1.37–2.66) | 1.81 (1.31–2.51) |
CKD and CS = 0–5 | 8.38 (6.19–11.34) | 2.84 (1.70–4.75) | 2.59 (1.52–4.41) |
Model 1: Unadjusted.
Model 2: Adjusted for demographic factors, history of cardiovascular diseases, hypertension, diabetes, physical inactivity, history of smoking, alcohol use, and albuminuria; stratified by gender and history of stroke.
Model 3: Model 2 variables plus CRP, hemoglobin, and serum 25-hydroxyvitamin D; stratified by gender and history of stroke.